DonCorleone77
Posted - 20 hours ago
$AZPN $EMR Aspen Technology board forms special committee to consider Emerson proposal Aspen Technology (AZPN) announced that its Board of Directors has formed a special committee composed of three independent directors to consider the non-binding proposal from Emerson Electric (EMR) received on November 5 . Emerson and its affiliates currently own 57.4% of the company's outstanding common shares. The Special Committee is composed of Board Chair Robert Whelan, Jr., who will serve as Chair of the Special Committee, Arlen Shenkman and David Henshall. Qatalyst Partners and Citi are serving as independent financial advisors to the Special Committee and Skadden, Arps, Slate, Meagher & Flom LLP is serving as its legal counsel in connection with its review and evaluation of the proposed transaction. The Company reiterates that no action is required by its shareholders at this time.
ChristaBoarts
Posted - 1 day ago
$EMR CRDL’s focus on heart disease therapies, including pericarditis, positions it as a leader in a high-growth sector with CardiolRx™ at the helm.
Shlobby
Posted - 4 days ago
$EMR watch this one go for a bit
QuantInsider
Posted - 6 days ago
Noticed something interesting today with $EMR—options trading shot up to 14.5 times the normal volume. That's quite a spike and usually suggests some serious institutional interest might be at play. Just curious what everyone thinks this could mean for EMR's future. Is it just a blip on the radar, or is there something more worth watching?
TegridyStocks
Posted - 1 week ago
$EMR monster
erevnon
Posted - 1 week ago
UBS assumes Emerson Electric $EMR at Neutral rating and raises the price target to https://marketsblock.com/stock-upgrades-and-downgrades/
IN0V8
Posted - 1 week ago
$EMR Opportunity Citigroup raises target price to $140 from $128 Oppenheimer raises target price to $150 from $125
swingingtech
Posted - 2 weeks ago
$EMR
https://wallstreetwaves.com/emerson-electric-stock-analyst-estimates-ratings/
erevnon
Posted - 2 weeks ago
Deutsche Bank maintains Emerson Electric $EMR at Buy and raises the price target from $136 to https://marketsblock.com/stock-upgrades-and-downgrades/
JackDarwin
Posted - 2 weeks ago
$EMR Bullish Gap Up Formed With High Volume. https://www.stockaio.com/US/ai/Stock/EMR/Candlestick
EarningsCallSamurAI
Posted - 2 weeks ago
$EMR Growth: Emerson's acquisition of AspenTech is set to enhance its software-defined automation capabilities, creating significant value for stakeholders. The $2B stock repurchase plan for fiscal 2025 underscores Emerson's commitment to shareholder returns. Project activity remains robust, with an $11.2B funnel driven by demand in LNG, life sciences, and decarbonization sectors. Growth prospects in the industrial software market, bolstered by the AspenTech acquisition, are strong, with anticipated high single-digit growth and recurring revenue potential. Additionally, resilience in process and hybrid markets and expected cost synergies from AspenTech contribute positively to Emerson's outlook. Headwinds: However, the company faces challenges, including weak demand in China and slow recovery in automotive and discrete automation markets, particularly in the EV sector. Check link bio for more!
PenkeTrading
Posted - 2 weeks ago
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Emerson Electric Company. Is that bullish or bearish? $EMR #RsiOverbought #NYSE
stockleapp
Posted - 2 weeks ago
$EMR Emerson Electric Q4 - $1.2B in dividends expected for 2025🏭 EPS: $1.48 15% Y/Y (Est. $1.47) Revenue: $4.62B +13% Y/Y (Est. $4.56B) "We are energized to complete our transformation and continue creating value for shareholders over the near- and long-term” - Lal Karsanbhai, CEO
Estimize
Posted - 2 weeks ago
$EMR reported 1.48 EPS and 4,619 revenue for Q4.
http://www.estimize.com/intro/emr?chart=historical&metric_name=eps&utm_content=EMR&utm_med
StocktwitsNews
Posted - 2 weeks ago
Emerson Electric Stock Soars After Upbeat Q4, Proposal To Fully Acquire AspenTech: Retail Cheers The Deal. $EMR $AZPN https://stevents.onelink.me/wmCS/1ekh690k
mnsiva
Posted - 2 weeks ago
$EMR No so great
MakingDreamsReality
Posted - 2 weeks ago
PM mOOvers 👀 $ZVSA - ZyVersa Therapeutics Highlights Data Showing The Potential Of Inflammasome Inhibition To Protect Pancreatic Islet Beta Cells And Attenuate Progression From Obesity To Insulin Resistance And Type 2 Diabetes $AGFY -Agrify Secures Financing from Green Thumb Industries and Announces New Leadership $PLTR - Palantir Technologies Non-GAAP EPS of $0.10 beats by $0.01, revenue of $725.52M beats by $21.83M, PLTR Earnings: Palantir Soars 13% after Raising Guidance $HIMS - Hims & Hers Health Q3 2024 Adj EPS $0.32 Beats $0.04 Estimate, Sales $401.60M Beat $382.20M Estimate $EMR -Emerson Electric Q4 2024 Adj. EPS $1.48 Beats $1.47 Estimate, Sales $4.619B Beat $4.566B Estimate
OpenOutcrier
Posted - 2 weeks ago
$EMR (+5.6% pre) Emerson Electric (NYSE:EMR) Exceeds Q3 Expectations, Stock Soars https://ooc.bz/l/46871
DonCorleone77
Posted - 2 weeks ago
$EMR Here is the full corrected report: Emerson reports Q4 adjusted EPS $1.48, consensus $1.47 Reports Q4 revenue $4.62B, consensus $4.57B. "Emerson completed an outstanding fiscal 2024, with strong underlying sales growth, operating leverage, adjusted earnings per share and cash generation. I want to thank our employees around the world for their commitment and passion which were integral to delivering these results. We have done an exceptional job integrating Test & Measurement with $100 million of synergies realized in the first year, and we remain resolute in our focus on executing at a world-class level, guided by our Emerson Management System. Emerson's leading technology, alignment with secular trends and customer focus provide confidence for continued momentum in fiscal 2025. We have made significant progress on our value-creation roadmap over the past three years, and the strategic actions announced today mark the final phase of our portfolio transformation to an industrial technology leader delivering advanced automation solutions. The actions we are taking, combined with our solid fiscal 2024 financial results, demonstrate the benefits and potential of Emerson's higher growth and higher margin portfolio. We are energized to complete our transformation and continue creating value for shareholders over the near- and long-term," said Emerson President and Chief Executive Officer Lal Karsanbhai.
DonCorleone77
Posted - 2 weeks ago
$EMR Emerson announces $2B repurchase program Emerson also announced that it plans to repurchase approximately $2B of its common stock in fiscal year 2025 increasing its total capital returned to shareholders to approximately 100% of the guided free cash flow. Emerson expects to complete approximately $1B of the repurchase by the end of the first fiscal quarter. The announced repurchase underscores Emerson's commitment to driving shareholder returns and confidence in the company's strong outlook, significant free cash generation and benefits of the actions announced today. Assuming successful completion of the transactions, Emerson expects total net leverage to be less than 2x by the end of fiscal year 2025 and expects to maintain its A2/A credit rating.
DonCorleone77
Posted - 2 weeks ago
$EMR Emerson to explore strategic alternatives for Safety & Productivity segment Emerson also announced that it is exploring strategic alternatives for its Safety & Productivity segment, including a cash sale, to maximize shareholder value. The segment, which includes Emerson's legacy tools businesses, contributed $1.4B of sales to Emerson in fiscal year 2024, with 24.5% Adjusted Segment EBITA margins. There is no deadline or definitive timetable set for completion of the strategic alternatives process or assurance that the process will result in any transaction. Emerson does not intend to make further announcements regarding the review of strategic alternatives, beyond the conference call, unless and until the board approves a specific transaction or otherwise determines further disclosure is appropriate or necessary.
DonCorleone77
Posted - 2 weeks ago
$AZPN $EMR Interesting.... Emerson proposes to acquire Aspen Technology for $240 per share in cash Emerson (EMR) announced three strategic and financial actions in the final phase of its portfolio transformation. Emerson has made a proposal to acquire all outstanding shares of common stock of AspenTech (AZPN) not already owned by Emerson for $240 per share in cash. The proposed transaction follows Emerson's 55% majority investment in AspenTech, which was completed in 2022. Emerson currently owns approximately 57% of AspenTech's outstanding shares of common stock. Upon completion of the transaction, AspenTech would become a wholly owned subsidiary of Emerson. Emerson has commenced a process to explore strategic alternatives, including a cash sale, for the Safety & Productivity segment, which comprises the remaining businesses not related to automation in Emerson's portfolio. Emerson plans to repurchase approximately $2B of its common stock in fiscal year 2025, with approximately $1B of the repurchase expected to be completed in the first quarter of fiscal year 2025. Emerson's proposed $240 per share in cash to acquire all outstanding shares of AspenTech common stock not already owned represents a multiple of 29x consensus estimates for AspenTech's fiscal year 2025 Adjusted EBITDA, a multiple consistent with the forward multiple paid in its original transaction for AspenTech. Emerson's proposal represents a 35% premium to the company's undisturbed share price of $177.84 on August 6, and an 8% premium to the undisturbed 52 week high of $221.94 through August 6, the date immediately prior to Emerson's August 7 earnings call, when active transaction speculation began in the market, including in multiple published analyst reports. The proposal implies a fully diluted market capitalization for AspenTech of $15.3B and an enterprise value of $15.1B. Emerson expects the impact of this proposed transaction with synergies to be neutral to adjusted EPS in fiscal 2025. Emerson has delivered its proposal in a letter to AspenTech's board of directors, filed with the SEC.
DonCorleone77
Posted - 2 weeks ago
$EMR Correction: Emerson reports Q4 adjusted EPS $1.48, consensus $1.47 Reports Q4 revenue $4.62B, consensus $4.57B.
Tokenist
Posted - 2 weeks ago
🚨EARNINGS ALERT🚨 Notable earnings released for today: Emerson Electric Company $EMR: $1.48 EPS vs $1.47 est. / $4.62B Revenue vs $4.57B est. Marathon Petroleum Corp $MPC: $1.87 EPS vs $1.04 est. / $35.37B Revenue vs $34.34B est. Gartner Inc $IT: $2.5 EPS vs $2.37 est. / $1.5B Revenue vs $1.48B est. Fortis Inc $FTS: $0.85 EPS vs $0.6 est. / $ -- Revenue vs $2.16B est.
DonCorleone77
Posted - 2 weeks ago
$EMR Emerson sees FY25 adjusted EPS view to $5.85-$6.05, consensus $5.89 Sees FY25 revenue up 3.5%-5.5%. Sees FY25 operating free cash flow $3.6B-$2.7B. The company said, "2025 outlook assumes approximately $1.2 billion of dividend payments."
DonCorleone77
Posted - 2 weeks ago
$EMR Emerson sees Q1 adjusted EPS $1.25-$1.30, consensus $1.28 Sees Q1 revenue up 2.5%-3.5%. Karsanbhai continued, "We have made significant progress on our value-creation roadmap over the past three years, and the strategic actions announced today mark the final phase of our portfolio transformation to an industrial technology leader delivering advanced automation solutions. The actions we are taking, combined with our solid fiscal 2024 financial results, demonstrate the benefits and potential of Emerson's higher growth and higher margin portfolio. We are energized to complete our transformation and continue creating value for shareholders over the near- and long-term."
DonCorleone77
Posted - 2 weeks ago
$EMR Emerson reports Q4 adjusted EPS $1.29, consensus $1.47 Reports Q4 revenue $4.09B, consensus $4.57B. "Emerson completed an outstanding fiscal 2024, with strong underlying sales growth, operating leverage, adjusted earnings per share and cash generation. I want to thank our employees around the world for their commitment and passion which were integral to delivering these results," said Emerson president and CEO Lal Karsanbhai. "We have done an exceptional job integrating Test & Measurement with $100 million of synergies realized in the first year, and we remain resolute in our focus on executing at a world-class level, guided by our Emerson Management System. Emerson's leading technology, alignment with secular trends and customer focus provide confidence for continued momentum in fiscal 2025."